Jilin Haotai Health Industry Development Co., Ltd. is exhibiting at the 23rd China International Pharmaceutical Ingredients Exhibition.
2025-06-24
"Leading with Innovation, Achieving Win-Win through Integration"—Haotai Health Advances into the Global Pharmaceutical Supply Chain
The 23rd China Pharmaceutical Ingredients Exhibition (CPHI China)
Time: June 24, 2025 – June 26, 2025
Location: Shanghai New International Expo Center (SNIEC)
Booth: E12B11
Organizers: Informa Markets, China Chamber of Commerce for Import & Export of Medicines & Health Products, and Shanghai Bohua International Exhibition Co., Ltd.
From June 24 to 26, 2025, CPHI & PMEC China (the 23rd World Pharmaceutical Ingredients China and the 18th World Pharmaceutical Machinery, Packaging Equipment and Materials China Exhibition) will be held at the Shanghai New International Expo Center.
At a critical juncture when China is deeply integrating with the global economy, how the pharmaceutical industry can build a globally competitive innovation ecosystem has become a pressing issue. As a “calling card” leading China’s pharmaceutical industry onto the world stage, the joint CPHI & PMEC China exhibition, anchored in a global perspective, professional depth, and differentiated strengths, is helping China’s pharmaceutical sector unlock a new paradigm. This year’s CPHI China, themed “Innovating with Intelligence, Fostering Integration for Mutual Success,” has attracted over 3,500 leading domestic and international companies and more than 100,000 professional visitors from home and abroad. The exhibition area has exceeded 230,000 square meters, providing an efficient platform for connecting and collaborating across the global pharmaceutical value chain.
On the first day of this exhibition (June 24), Haotai Health focused on sharing bio-based pharmaceutical intermediate raw materials. In areas such as sodium deoxycytidine, pulmonary phospholipids, heparin, bilirubin, chondroitin sulfate, bovine liver extract, and bovine prostate extract, we presented to customers and visitors from Russia, India, South Korea, Iran, Egypt, the Netherlands, the United Kingdom, Germany, France, Belgium, Italy, Switzerland, and Spain our comprehensive service network—from algorithm R&D and gene synthesis to pilot-scale amplification and commercial production—along with tailored solution offerings. To this end, we prepared an abundance of industry case studies, specialized custom product solutions, and cutting-edge market insights. In total, we welcomed over 27 renowned brand enterprises from overseas and regions including Hong Kong, China, and received more than 6,000 visitor visits.
Tomorrow (June 25), we have scheduled meetings with five prospective clients from Belgium, Italy, Russia, India, and Iran. We will focus on sharing high-value-added products derived from Jilin Province’s distinctive resources—such as ginseng, Atractylodes macrocephala, corn silk, and wild chives—while continuing to promote to global prospective clients and audiences our integrated innovation system spanning the entire chain: “technological development—resource conversion—green manufacturing—industrial services.” This will enable Jilin’s smart manufacturing to shine brightly on the world stage.
The 12 scientists and technical experts from Haotai Health will also participate in eight conferences and forums focused on cutting-edge topics in specific vertical industries, covering diverse themes such as policy and regulatory interpretations, life science instruments, innovations in advanced process technologies, clean and environmentally friendly practices, and market trend analyses—thus providing significant impetus for the development and technological advancement of the pharmaceutical industry.
Haotai Health once again cordially invites you to visit our booth (Booth No.: E12B11) to engage in in-depth discussions with our professional business team, share experiences and insights together, and explore new opportunities in the pharmaceutical industry!
Related dynamics